OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Clinical Apheresis is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue	94
Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19	27
Convalescent plasma therapy in patients with COVID‐19	25
Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA‐associated vasculitis	23
Ninety days transplant free survival with high volume plasma exchange in Wilson disease presenting as acute liver failure	20
Efficacy of convalescent plasma therapy for COVID‐19: A systematic review and meta‐analysis	19
The role of double filtration plasmapheresis in hypertriglyceridemic pancreatitis: A propensity score matching analysis	19
Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE)	17
Unstimulated apheresis for chimeric antigen receptor manufacturing in pediatric/adolescent acute lymphoblastic leukemia patients	14
Anti‐MDA‐5 antibody‐positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease treated with therapeutic plasma exchange: A case series	13
Red blood cell exchange to avoid intubating a COVID‐19 positive patient with sickle cell disease?	13
The use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 2019: A critical appraisal of the current evidence	13
Immunoadsorption and plasma exchange—Efficient treatment options for neurological autoimmune diseases	13
Rapid reduction in triglyceride levels by therapeutic plasma exchange in patients with hypertriglyceridemic pancreatitis	13
Efficacy of therapeutic plasma exchange for treatment of autoimmune hemolytic anemia: A systematic review and meta‐analysis of randomized controlled trials	12
A matched cohort study of convalescent plasma therapy for COVID‐19	12
Effect of TPE vs medical management on patient outcomes in the setting of hypertriglyceridemia‐induced acute pancreatitis with severely elevated triglycerides	11
Therapeutic plasma exchange for clinically amyopathic dermatomyositis (CADM) associated with rapidly progressive interstitial pneumonia	11
Vascular access for optimal hematopoietic stem cell collection	10
Special Issue Abstracts from the American Society for Apheresis 44th Annual Meeting April 26–28, 2023	10
Therapeutic plasma exchange in acute on chronic liver failure	10
Immune checkpoint inhibitor toxicity: A new indication for therapeutic plasma exchange?	10
Parasite burden and red blood cell exchange transfusion for babesiosis	9
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response	9
Incidence, diagnosis, and outcome of immune‐mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura	9

Efficacy of therapeutic plasma exchange in patients with Crimean‐Congo hemorrhagic fever	9
Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid‐resistant acute and chronic graft‐vs‐host disease after allogenic hematopoietic stem cell transplant	9
Therapeutic plasma exchange in a critically ill Covid‐19 patient	8
Initial experience with high‐volume plasma exchange in patients with acute liver failure	8
Plasmapheresis compared with conventional treatment for hypertriglyceridemia‐induced acute pancreatitis: A systematic review and meta‐analysis	8
Double‐blind, randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate‐to‐severe relapses of multiple sclerosis	7
Therapeutic plasma exchange for control of thyroid storm	7
Abstract	7
Therapeutic plasma exchange and dextran‐sulfate plasma adsorption as extracorporeal treatments of extremely preterm preeclampsia with fetal growth restriction	7
Therapeutic plasma exchange with albumin as a valuable method of preparing thyrotoxic patients for a life‐saving thyroidectomy	7
Potential differences between double‐filtration plasmapheresis and therapeutic plasma exchange in the treatment of acute hypertriglyceridemic pancreatitis	7
Peripheral blood stem cell collection in children with extremely low body weight (≤8 kg). What have we learned over the past 25 years and where are the limits?	6
Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy	6
Pilot study of a new online extracorporeal photopheresis system in patients with steroid refractory or dependent chronic graft vs host disease	6
Treatment of refractory myasthenia gravis by double‐filtration plasmapheresis and rituximab: A case series of nine patients and literature review	6
Hemostatic effects of therapeutic plasma exchange: A concise review	6
Double filtration plasmapheresis in hypertriglyceridemic pancreatitis: Triglyceride levels and clinical outcomes	6
Comparison of three modalities of plasmapheresis on coagulation: Centrifugal, single‐membrane filtration, and double‐filtration plasmapheresis	6
Apheresis medicine in the era of advanced telehealth technologies: An American Society for Apheresis position paper Part I: Understanding the basic technologies and apheresis medicine practice models	6
The ABC's of disaster management: Managing apheresis operations during the SARS‐CoV‐2 pandemic	6
Pediatric double positive anti‐glomerular basement membrane antibody and anti‐neutrophil cytoplasmic antibody glomerulonephritis—A case report with review of literature	6
“Plasma exchange in a bottle”: An overview of efgartigimod for apheresis practitioners	6
Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group	6
Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster‐randomized controlled trial	6
Source plasma deferral trends: A 3‐year analysis of 255 centers in the United States	6
Pyoderma gangrenosum in an ulcerative colitis patient during treatment with vedolizumab responded favorably to adsorptive granulocyte and monocyte apheresis	6
Development of iron deficiency anemia in patients undergoing extracorporeal photopheresis: Comparison of the UVAR and CELLEX instruments	5
Ultrasound‐based criteria for adequate peripheral venous access in therapeutic apheresis procedures	5
Description of parallel and sequential configurations for concurrent therapeutic plasma exchange and continuous kidney replacement therapy in adults	5
The first pediatric case of hemophagocytic lymphohistiocytosis secondary to Crimean‐Congo haemorrhagic fever successfully treated with therapeutic plasma exchange accompanying ribavirin and	5
Cardiovascular events in patients with familial hypercholesterolemia and hyperlipoproteinaemia (a): Indications for lipoprotein apheresis in Poland	5
Role of extracorporeal photopheresis in the management of children with graft‐vs‐host disease	5
Novel use of a midline catheter for therapeutic and donor apheresis in children and adults	5
Effect of immunoadsorption alone or combined with membrane filtration on hemostasis parameters	5
Neonatal Fc receptor blockade as emerging therapy in diseases with plasma exchange indications	5
Lipoprotein apheresis and PCSK9 inhibitors for severe familial hypercholesterolaemia: Experience from Australia and New Zealand	5
Double‐filtration plasmapheresis combined with immunosuppressive treatment for severe pemphigus: 10 years' experience of a single center in China	5
Lack of defined apheresis collection criteria in publicly available CAR‐T cell clinical trial descriptions: Comprehensive review of over 600 studies	5
Therapeutic plasma exchange is a safe and effective bridge therapy in patients with alcohol‐associated ACLF not having immediate prospects for liver transplantation—A case‐control, pilot st	5
Exogenous insulin antibody syndrome treated with plasma exchange after an incomplete response to immunosuppressive therapy	4
Retrospective comparison between COBE SPECTRA and SPECTRA OPTIA apheresis systems for hematopoietic progenitor cells collection for autologous and allogeneic transplantation in a single center	4
Therapeutic plasmapheresis for the treatment of thyrotoxicosis: A retrospective multi‐center study	4
Comparison of spectra optia and amicus cell separators for autologous peripheral blood stem cell collection	4
Acquired factor XIII deficiency in patients under therapeutic plasma exchange: A poorly explored etiology	4
Membrane‐based therapeutic plasma exchange: Hemodynamics and operational characteristics leading to procedure failure	4
Tolerance and complications of therapeutic plasma exchange by centrifugation: A single center experience	4
Clinical experience with maintenance therapeutic plasma exchange in refractory generalized myasthenia gravis	4
Analysis of laboratory parameters for optimal autologous peripheral blood stem cell collection from lymphoma and myeloma patients	4
Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants	4
Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center	4

How to write a manuscript for peer review	4
Trends in the use of therapeutic plasma exchange in multiple myeloma	4
A comparative study of five plateletpheresis machines in a tertiary care center of India: AmiCORE vs COM.TEC vs Haemonetics MCS+ vs Spectra Optia vs Trima A	4
Plerixafor‐based mobilization in pediatric healthy donors with unfavorable donor/recipient body weight ratio resulted in a better CD34⁺ collection yield: A retrospective analysis	4
Use of therapeutic plasma exchange in heparin‐induced thrombocytopenia: A population‐based study	4
Therapeutic plasma‐exchange improves short‐term, but not long‐term, outcomes in patients with acute‐on‐chronic liver failure: A propensity score‐matched analysis	4
Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies	4
Peptide GAM immunoadsorption in anti‐PLA₂R positive autoimmune membranous nephropathy. The PRISM trial	4
The role of therapeutic plasma exchange in clinically amyopathic dermatomyositis with MDA‐5 antibody: A case report and review of the literature	4
Apheresis medicine in the era of advanced telehealth technologies: An American Society for Apheresis position paper part II: Principles of apheresis medical practice in a 21st century electronic medic	4
Therapeutic plasma exchange for peripheral neuropathy associated with trisulfated heparan disaccharide IgM antibodies: A case series of 17 patients	3
Treatment of comatose patient from cyclobenzaprine overdose with therapeutic plasma exchange	3
Efficacy of plasmapheresis and semi‐selective immunoadsorption for removal of anti‐HLA antibodies	3
Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experience	3
Efficacy of intravenous combined immunosuppression with plasmapheresis in adult patients with refractory primary focal segmental glomerulosclerosis	3
Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study	3
Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children	3
Efficacy of peripheral arterial access for peripheral blood stem cells collection	3
Treatment of antibody‐mediated rejection with double‐filtration plasmapheresis, low dose IVIg plus rituximab after kidney transplantation	3
Therapeutic plasma exchange for steroid refractory idiopathic inflammatory myopathies with interstitial lung disease	3
Therapeutic thrombocytapheresis in myeloproliferative neoplasms: A single‐institution experience	3
Current state of therapeutic apheresis and cellular therapy education for transfusion medicine fellows in the United States	3
The role of treatment with plasma exchange therapy in two pediatric toxic epidermal necrolysis cases related to COVID‐19	3
ECP as additional immunomodulation in idiopathic hyperammonemia and recurrent hypercapnic respiratory failure early post lung transplantation	3
Plerixafor added to G‐CSF allows mobilization of a sufficient number of hematopoietic progenitors without impacting the efficacy of TCR‐alpha/beta depletion in pediatric haploide	3
Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura	3
Mobilized and apheresis‐collected endothelial progenitor cells with plerixafor	3
Immunogenic and immunotolerogenic effects of extracorporeal photopheresis in high immunological risk kidney recipients. A single center case series	3
A strategy to conserve personal protective equipment while performing therapeutic plasma exchange in a patient with COVID‐19	3
Analysis of 52 240 source plasma donors of convalescent COVID‐19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation	3
Severe complications in a 25‐year‐old male after brown recluse spider bite treated by therapeutic plasma exchange: A case report and review of other case studies	3
Infectious risks in patients treated with extracorporeal photopheresis for graft‐versus‐host disease: A retrospective cohort study	3
Addition of plerixafor in poorly mobilized allogeneic stem cell donors	3
Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: A systematic scoping review of outcome measures used	3
Application of the French TMA Reference Center Score and the mortality in TTP Score in de novo and relapsed episodes of acquired thrombotic thrombocytopenic purpura at	3
Fibrinogen reconstitution after therapeutic apheresis: Comparison of double‐filtration plasmapheresis, plasma exchange, and immunoadsorption	3
Positive effects of ultrasound‐guided peripheral IV insertion on pediatric sickle cell anemia/thalassemia patients receiving automated red cell exchange procedures or chronic tra	3
Impact of the number of cryopreserved CD34⁺ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation:	3
Rheopheresis for severe peripheral arterial disease in hemodialysis patients: A clinical series	3
Adsorptive granulomonocytapheresis alters the gut bacterial microbiota in patients with active ulcerative colitis	3
Terumo spectra optia leukapheresis of cynomolgus macaques for hematopoietic stem cell and T cell collection	3
A case of severe DRESS syndrome treated with therapeutic plasma exchange and intravenous immunoglobulin therapy	3
Autologous hematopoietic stem cell product contaminated with Salmonella due to occult salmonellosis in an asymptomatic donor	3